NCT00209443View on ClinicalTrials.gov

A Safety and Efficacy Clinical Study to Evaluate the Narrowing of the Aorto-iliac Arteries While Using Gadodiamide

PHASE3CompletedINTERVENTIONAL
Enrollment

407

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

February 28, 2006

Study Completion Date

February 28, 2006

Conditions
Aorto-iliac StenosisArterial Occlusive Diseases
Interventions
DRUG

Gadodiamide Injection

Trial Locations (1)

Unknown

Amersham Buchler GmbH & Co. KG, Ismaning

Sponsors

Lead Sponsor

GE Healthcare
All Listed Sponsors
lead

GE Healthcare

INDUSTRY